Foresite Capital Management Iii, LLC Sangamo Therapeutics, Inc Transaction History

Foresite Capital Management Iii, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $2.53 Million - $4.41 Million	-265,605 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $1.54 Million - $2.2 Million	111,143 Added 71.95%	265,605 $3.77 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $2.58 Million - $4.07 Million	154,462 New	154,462 $2.94 Million
Q3 2017 Nov 13, 2017	SELL	$8.4 - $15.0 $1.29 Million - $2.31 Million	-154,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	154,000	154,000 $1.36 Million

134

86.5M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $312M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.